by The cervical spondylosis treatment market consists of various non-surgical and surgical treatment solutions used to manage neck pain caused by cervical spondylosis. Non-surgical treatments include analgesia, physical therapy, chiropractic treatment, and cervical collars or braces. Meanwhile, surgical treatments comprise anterior cervical discectomy and fusion (ACDF), cervical disc replacement, laminoplasty, laminectomy, and foraminotomy. The global cervical spondylosis treatment market size is estimated to be valued at US$ 6.65 Mn in 2024 and is expected to exhibit a CAGR of 3.5% over the forecast period between 2024 and 2030.
Key Takeaways
Key players operating in the cervical spondylosis treatment market size are American Tower Corporation, AT&T Inc., Bharti Infratel Limited, China Tower Corporation, Crown Castle International Corporation, GTL Infrastructure Ltd, Helios Tower Africa, SBA Communications Corporation, T-Mobile Tower, and Viom Networks.
The growing geriatric population suffering from cervical spondylosis due to osteoarthritis is a key factor driving the demand for both surgical and non-surgical treatment solutions. It is estimated that over 60% of people aged above 60 years suffer from some form of cervical spondylosis.
Globalization and expansion of medical value travel has enabled access to advanced treatment solutions such as cervical disc replacement and minimally invasive surgeries in emerging economies, thereby supporting the global expansion of the cervical spondylosis treatment market.
Market Key Trends
Increasing adoption of motion-preserving devices is one of the key trends in the cervical spondylosis treatment market. Motion-preserving alternatives aim to reduce adjacent segment degeneration by preserving mobility in cervical spine sections. Companies are focusing on developing innovative cervical disc replacement technologies that enable a full range of neck motion to address the limitations of fusion surgeries.
Porter’s Analysis
Threat of new entrants: High capital requirement and established brand value of existing players make entry difficult.
Bargaining power of buyers: Buyers have moderate bargaining power due to availability of alternative treatment options.
Bargaining power of suppliers: Suppliers have moderate bargaining power due to availability of substitutes and input materials.
Threat of new substitutes: Threat of substitute is moderate as new alternative treatment options are emerging.
Competitive rivalry: Intense competition exists among existing players to gain higher market share.
Geographical Regions
North America currently holds the largest market share primarily due to increasing cervical spondylosis cases and growing geriatric population.
Asia Pacific region is expected to grow at the fastest pace during the forecast period owing to developing healthcare infrastructure and rising medical tourism across India and China.
